State of Cancer Immunotherapy
Immunotherapy Has a Long History1-5
Immunotherapy has been under evaluation for more than a century, but only recently has it entered a renaissance phase with approval of multiple agents for the treatment of cancer.
FDA-Approved Immunotherapies*,1,4,6-8
Monoclonal antibodies |
1997, 1998, 2000, 2001, 2002, 2003, 2004, 2006, 2009 |
Checkpoint inhibitor |
2011 |
Cytokines |
1986, 1992, 1995,
1998 |
Therapeutic vaccine |
2010 |
*Not inclusive of all immunotherapy classes.
The Future of Immunotherapy
Clinical research in immunotherapy is rapidly increasing:
- From 2009 to 2012, abstracts at major conferences have doubled9
- There are approximately 800 ongoing clinical trials in various phases for cancers such as breast, colon, head and neck, and kidney10
Learn More About Clinical Considerations